180 Life Sciences Granted An Additional Extension By Nasdaq Hearing Panel To Regain Compliance With Continued Listing Requirements
Portfolio Pulse from Benzinga Newsdesk
180 Life Sciences Corp. (NASDAQ:ATNF) has been granted an extension by the Nasdaq Listing Qualifications Panel to regain compliance with Nasdaq's continued listing requirements. The company has until September 20, 2024, to meet the Equity Rule and maintain its listing on Nasdaq.
July 23, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
180 Life Sciences Corp. has been granted an extension by Nasdaq to regain compliance with listing requirements by September 20, 2024. This extension provides the company with additional time to meet the Equity Rule and maintain its listing on Nasdaq.
The extension granted by Nasdaq provides 180 Life Sciences with additional time to meet compliance requirements, which is a positive development for the company. This reduces immediate delisting risk and may stabilize investor confidence in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100